| Affordable Dentures & Implants - Oklahoma, Pllc | |
|
1875 N Highway 66 Ste A Catoosa OK 74015-3072 | |
| (918) 266-2906 | |
| Not Available |
| Full Name | Affordable Dentures & Implants - Oklahoma, Pllc |
|---|---|
| Speciality | Dentist |
| Location | 1875 N Highway 66 Ste A, Catoosa, Oklahoma |
| Authorized Official Name and Position | Haley Wooster (ENROLLMENT SPECIALIST) |
| Authorized Official Contact | 7127338551 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Affordable Dentures & Implants - Oklahoma, Pllc 1875 N Highway 66 Ste A Catoosa OK 74015-3072 Ph: (918) 266-2906 | Affordable Dentures & Implants - Oklahoma, Pllc 1875 N Highway 66 Ste A Catoosa OK 74015-3072 Ph: (918) 266-2906 |
| NPI Number | 1164604203 |
|---|---|
| Provider Enumeration Date | 11/30/2007 |
| Last Update Date | 09/20/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164604203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 3749 (Oklahoma) | Primary |
News Archive
Diabetes mellitus and gout are ranked among the most common metabolic disorders in Western industrialised countries: According to figures published by the World Health Organization (WHO), around 60 million Europeans suffer from diabetes (2) and 18 million Europeans suffer from gout (3).
Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) approved the reformulation of the stomach acid suppressant, PROTONIX(R) I.V. (pantoprazole sodium) for Injection.
Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has closed a $3.0-million round of funding comprised of convertible notes. The funding was secured from current investors in the company. The proceeds will be used to advance the clinical trial of the company's StrataGraft® living human skin substitute tissue. The company expects to begin Phase IIb of the trial during the second half of 2010.
Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that its Symphony System was profiled in the November 29, 2010 issue of Diabetes Health magazine.
A collaboration between researchers at the Babraham Institute and the University of Manchester has mapped the physical connections occurring in the genome to shed light on the parts of the genome involved in autoimmune diseases. Using a new technique, called Capture Hi-C, the team revealed novel insights into how changes in the genetic sequence have a biological effect and increase the risk of disease.
› Verified 6 days ago
Catoosa Dental Care, Plc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1755 N Highway 66, Suite # D, Catoosa, OK 74015 Phone: 918-266-3866 Fax: 918-266-3880 |